Beyond Air’s Earnings Call Highlights Robust Growth and Expansion

Beyond Air ((XAIR)) has held its Q4 earnings call. Read on for the main highlights of the call.

Beyond Air’s recent earnings call conveyed a generally positive sentiment, underscored by remarkable revenue growth and promising future guidance. The company showcased its successful international expansion, although it acknowledged financial challenges such as net loss and cost exceedances.

Record-Breaking Revenue Growth

For the fiscal year ended March 31, 2025, Beyond Air reported an impressive 220% increase in revenue, reaching $3.7 million compared to $1.2 million for the same period last year. This significant growth highlights the company’s strong performance and its ability to capture market opportunities effectively.

Strong Revenue Guidance

Looking ahead, Beyond Air provided robust revenue guidance of $12 million to $16 million for the full fiscal year ending March 31, 2026. This forecast indicates the company’s confidence in sustaining its high growth trajectory, driven by strategic initiatives and market demand.

Expansion into International Markets

Beyond Air has made significant strides in its international expansion efforts, extending its commercial program across Europe, Southeast Asia, and the Middle East. The company has successfully signed distribution agreements in over two dozen countries, enhancing its global footprint and market reach.

FDA Submission for Next-Generation Device

In a strategic move, Beyond Air submitted a PMA supplement for its next-generation LungFit PH II device. This smaller, lighter, and more transportable version of the current FDA-approved system is designed to enhance operational efficiency and broaden its application scope.

Notable Partnerships and Recognition

Beyond Air announced a key partnership with Vanderbilt University Medical Center, designating it as the first luminary site for LungFit PH. Additionally, the appointment of Bob Goodman to its Board of Directors marks a significant step in strengthening the company’s leadership and strategic direction.

Net Loss and Gross Profit Challenges

Despite the positive revenue growth, Beyond Air reported a net loss of $46.6 million for the fiscal year, with a gross profit loss of $1.7 million. The cost of revenue exceeded revenue due to depreciation and upgrade costs, highlighting areas that require strategic financial management.

Operational and Market Challenges

The company faced operational challenges, with the cost of revenue amounting to $5.4 million, driven by the depreciation of LungFit devices and one-time upgrade costs. Additionally, geopolitical factors and regulatory processes present challenges in international markets, requiring careful navigation.

Forward-Looking Guidance

Beyond Air’s forward-looking guidance remains optimistic, with a forecast of at least $1.7 million in revenue for the quarter ending June 30, 2025. This represents over a 45% sequential growth and more than 145% year-over-year growth. The company also anticipates continued international expansion and has begun shipping LungFit PH units outside the U.S.

In summary, Beyond Air’s earnings call reflected a positive outlook, driven by substantial revenue growth and strategic international expansion. While financial challenges persist, the company’s strong guidance and innovative initiatives position it well for future success.